| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Maia Biotechnology, Inc. (MAIA) has 9 insiders with recent SEC Form 4 filings, including 19 buys and 0 sells. MAIA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.52M | $2.16M | - | |
| CEO | 976.1K | $1.39M | - | |
| Other | 60.0K | $85.2K | - | |
| Other | 46.5K | $66.0K | - | |
| Dir | 29.8K | $42.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2023 | Guerrero Ramiro | Director | Buy | 1,352 | $4.25 | $5,741.19 | +0.2% | -45.3% | -65.8% | |
| Mar 6, 2023 | Smith Stan | Director | Buy | 7,103 | $4.40 | $31,282.53 | +0.7% | -47.8% | -67.1% | |
| Mar 3, 2023 | Vitoc Vlad | Chief Executive Officer | Buy | 2,443 | $4.47 | $10,917.96 | +0.2% | -44.1% | -69.7% | |
| Mar 2, 2023 | Smith Stan | Director | Buy | 221 | $4.47 | $988.47 | - | -46.6% | -70.2% | |
| Mar 1, 2023 | Vitoc Vlad | Chief Executive Officer | Buy | 1,557 | $4.49 | $6,988.11 | - | -46.7% | -70.9% | |
| Feb 28, 2023 | Smith Stan | Director | Buy | 1,838 | $4.48 | $8,232.05 | +0.2% | -45.9% | -68.9% | |
| Feb 22, 2023 | Smith Stan | Director | Buy | 1,301 | $4.48 | $5,830.76 | +0.1% | -44.0% | -66.9% | |
| Feb 17, 2023 | Vitoc Vlad | Chief Executive Officer | Buy | 73 | $4.25 | $310.25 | - | -45.5% | -65.6% | |
| Feb 17, 2023 | Guerrero Ramiro | Director | Buy | 60 | $4.25 | $255.00 | - | -45.5% | -65.6% | |
| Feb 17, 2023 | Smith Stan | Director | Buy | 137 | $4.25 | $582.25 | - | -45.5% | -65.6% |